Alpha Tau to Present at Biotech Showcase and Participate in LifeSci Advisors Corporate Access Event

Alpha Tau Medical Announces Third Quarter 2022 Financial Results and Provides Corporate Update

Alpha Tau to Present at Upcoming November Investor Conferences

Alpha Tau Announces Multiple Corporate Updates Ahead of 2022 Annual Meeting of the American Society

Acceptance in Major Peer-Reviewed Journals of two Landmark Pre-Clinical Studies

Alpha Tau Appoints Industry Veteran Peter Melnyk as Chief Commercial Officer

Alpha Tau Medical to Participate in Upcoming September Investor Conferences

Alpha Tau Medical Announces Second Quarter 2022 - Financial Results and Provides Corporate Update

Alpha Tau and MIM Software Announce Collaboration for Alpha DaRT Treatment Planning

Alpha Tau Hosting Key Opinion Leader Meeting on Alpha DaRT Clinical Trials